https://dream.weekday.works/redirectToHiringCopilotExtension/

IFM Investors

Venrock

Menlo Ventures

Temasek

Aisling Capital

BB Biotech

Tekla Capital Management

International Biotechnology Trust

NB Capital

Liberty Bay Capital

Jindal Ventures Capital

Gilead is a developer of medicines to treat HIV/AIDS, liver diseases, cancer & others. It is a research-based biopharmaceutical company that discovers, develops, and commercializes innovative medicines in areas of unmet medical need. It has developed many medicines such as Lenacapavir capsid inhibitor (GS-6207) for HIV, Long-acting treatment: 2 bNAbs (GS-5423, GS-2872), Selgantolimod TLR-8 agonist (GS-9688), PD-L1 inhibitor (GS-4224) HBV cure, and many more. In 2021, the company recorded annual revenues of $24.68B, and a net profit of $0.12B.In 2021, the company recorded annual revenues of $27.3B and a net profit of $6.22B

Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others

Abbott Laboratories is a Employee's Credit Union, helping thousands of people make sensible decisions for their long term success.

MidCap Financial

Rand McNally specialises in maps, navigation, road travel, and trip planning. Founded in 1856, the company provides products and services for consumers, the trucking and commercial transportation market, and educators. Rand McNally’s products and services include tablet-based in-head display for cars, trucks, RVs, etc, type pressure monitoring system, a comprehensive physical road atlas and a road atlas app.

Commercial Transportation, Travel & Mobile Resource Management